Researchers discovered that recurring arthritis triggered by cancer immunotherapy may be driven by immune cells that remember ...
Neurokinin receptor (NKR) antagonists are already widely used for treating menopausal hot flashes, representing a highly ...
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity ...
Tumours rely on surrounding cells, including cancer-associated fibroblasts, immune cells and blood vessels, to grow, spread ...
In a significant oncological breakthrough that could redefine therapeutics for difficult-to-treat malignancies, medical ...
Phase II clinical study (SMT112-216 / AK112-216 / NCT07877194). Built on Akeso's first-in-class immuno-oncology (IO) ...
Researchers coated the gold particles with polyethylene glycol (PEG) conjugates containing antibodies that recognize ...
A pan-cancer single-cell framework identifies 667 cell-specific long noncoding RNAs and thousands of functional pairs linked ...
Researchers used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, ...
A protein that helps cancer grow could become an unlikely ally in treating it, with laboratory and mouse experiments showing ...
An overlooked population of immune cells could offer a new way to attack one of the deadliest forms of lung cancer.
EGFR PACC-mutant NSCLC is one of the largest underserved patient populations within EGFR-driven lung cancer. Accounting for ...